Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Chunjin Ke"'
Autor:
Jing Luo, Xing Zeng, Yanan Wang, Le Li, Jihua Tian, Chunjin Ke, Zhenghao Liu, Yangjun Zhang, Zhiquan Hu, Chunguang Yang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Immune checkpoint inhibitors (ICIs) are the standard of care for metastatic renal cell carcinoma (RCC); however, most patients develop de novo or acquired resistance to ICIs. Oxidative phosphorylation (OXPHOS) has been rarely explored as a
Externí odkaz:
https://doaj.org/article/c882956adc034157b7dc1892cd924372
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9106-9115 (2023)
Abstract Background We analyzed the clinical data of patients with urachal carcinoma (UrC) in order to strengthen urologists' understanding of UrC and improve preoperative diagnosis. Methods The clinical data of 37 patients with UrC admitted to our h
Externí odkaz:
https://doaj.org/article/08ccff81f6084114936c8749d90e1b3f
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Background: Positive UroVysion™ fluorescence in situ hybridization (FISH) is generally considered as urothelial carcinoma (UC). We clarify if UroVysion™ FISH can be positive in carcinoma of non-urothelial lineages (CNUL), and verify the consisten
Externí odkaz:
https://doaj.org/article/415b8c0ac51e4940ba2badb56272e501
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
PurposeTo compare the cause-specific survival (CSS) and overall survival (OS) of patients with localized T3a renal cell carcinoma (RCC) after partial nephrectomy (PN) or radical nephrectomy (RN).MethodsWe obtained the demographic and clinicopathologi
Externí odkaz:
https://doaj.org/article/1f43e56e54964c02a48260e10b3e69ec
Publikováno v:
Applied Bionics and Biomechanics, Vol 2022 (2022)
Objective. To assess the effectiveness of gonadotropin-releasing hormone (GnRH) antagonists and agonists in the treatment of patients with hormone-sensitive prostate cancer (HSPC), thus providing valid data support for their clinical treatment. Metho
Externí odkaz:
https://doaj.org/article/7792465c0eb84d359740a30c559ee672
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Patients with hematuria who are positive for urinary fluorescence in situ hybridization (FISH) are generally considered to have urothelial carcinoma. We determined whether UroVysion FISH could be used for the diagnosis of urachal carcinom
Externí odkaz:
https://doaj.org/article/165b3844853542d680c9883e35551131
Autor:
Chunguang Yang, Chunjin Ke, Daoyuan Yue, Wengang Li, Zhiquan Hu, Wei Liu, Shuhua Hu, Shaogang Wang, Jihong Liu
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
Background: Frontline health professionals are a COVID-19-susceptible population during the outbreak of COVID-19, but prophylactic drugs against SARS-CoV-2 infection are to be explored.Method: Frontline health professionals diagnosed with COVID-19 be
Externí odkaz:
https://doaj.org/article/9876494a91c34996bb7b9b5b24d79b89
Publikováno v:
Translational Cancer Research. 11:3448-3457
Transurethral resection of bladder tumor (TURBT) combined with intravesical Bacillus Calmette-Guérin (BCG) perfusion is a widely accepted treatment for moderate or high risk non-muscular-invasive bladder cancer (BCa). Despite its effectiveness, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d0b4938748f7026729b8f9189821b8
https://doi.org/10.21037/tcr-22-1367
https://doi.org/10.21037/tcr-22-1367
Publikováno v:
Cancers. 14(21)
UroVysion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::825951ac42778fbf9f8ab743ddfbf958
https://pubmed.ncbi.nlm.nih.gov/36358841
https://pubmed.ncbi.nlm.nih.gov/36358841
Autor:
Chunjin Ke, Lu Xu, Maoyu Wang, Yinzhao Wang, Qian Zhou, Jinchao Chen, Zhihua Wang, Shaogang Wang, Zhiquan Hu, Chunguang Yang
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 41:50.e1-50.e9
Urachal carcinoma (UC) is a rare genitourinary cancer with an insidious onset, high risk of recurrence, and a poor prognosis. Surgical resection alone has difficulty in controlling the tumor. We aim to explore treatment options and prognostic risk fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4d9479ccff5168ddef3bb11dcffd7ac
https://doi.org/10.1016/j.urolonc.2022.09.017
https://doi.org/10.1016/j.urolonc.2022.09.017